Caroline Haglund

676 total citations
15 papers, 329 citations indexed

About

Caroline Haglund is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Caroline Haglund has authored 15 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Caroline Haglund's work include Glioma Diagnosis and Treatment (4 papers), Cancer Cells and Metastasis (3 papers) and Acute Myeloid Leukemia Research (2 papers). Caroline Haglund is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Cancer Cells and Metastasis (3 papers) and Acute Myeloid Leukemia Research (2 papers). Caroline Haglund collaborates with scholars based in Sweden. Caroline Haglund's co-authors include Rolf Larsson, Mårten Fryknäs, Joachim Gullbo, Peter Nygren, Linda Rickardson, Stig Linder, Pádraig D’Arcy, Malin Jarvius, Malin Wickström and Elin Lindhagen and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.

In The Last Decade

Caroline Haglund

14 papers receiving 321 citations

Peers

Countries citing papers authored by Caroline Haglund

Since Specialization

Citations

This map shows the geographic impact of Caroline Haglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Haglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Haglund more than expected).

Fields of papers citing papers by Caroline Haglund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Haglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Haglund. The network helps show where Caroline Haglund may publish in the future.

Co-authorship network of co-authors of Caroline Haglund

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Haglund. A scholar is included among the top collaborators of Caroline Haglund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Haglund. Caroline Haglund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity 2019 ·The Journal of Pathology ·Mia Niklasson, Tobias Bergström, Malin Jarvius, Anders Sundström, Frida Nyberg, Caroline Haglund, Rolf Larsson, Bengt Westermark, Bo Segerman, Anna Segerman	31
2	Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin 2017 ·Cell Reports ·Yiwen Jiang, Voichita D. Marinescu, Yuan Xie, Malin Jarvius, (unknown), Caroline Haglund, Sara K. Olofsson, Nanna Lindberg, Tommie Olofsson, (unknown), Göran Hesselager, Irina Alafuzoff, Mårten Fryknäs, Rolf Larsson, Sven Nelander, Lene Uhrbom	52
3	Abstract 4175: Targeting of a mesenchymal profile in order to sensitize multitherapy resistant glioblastoma clones 2017 ·Cancer Research ·Mia Niklasson, Malin Jarvius, Caroline Haglund, (unknown), Tobias Bergström, Frida Nyberg, Annika Hermansson, Mårten Fryknäs, Mats Gustafsson, Bo Segerman, Rolf Larsson, Bengt Westermark, Anna Segerman	1
4	Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia 2016 ·Biochemical Pharmacology ·(unknown), Muhammad Kashif, Caroline Haglund, Karl F. Blom, Martin Höglund, Charlotte Andersson, Mats G. Gustafsson, Anna Eriksson, Rolf Larsson	2
5	In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia 2016 ·Oncotarget ·(unknown), Saadia Hassan, (unknown), Caroline Haglund, Martin Höglund, Rolf Larsson, Joachim Gullbo	13
6	Malignancy and drug sensitivity of glioblastoma cells are affected by the cell of origin 2016 ·Yiwen Jiang, Voichita D. Marinescu, Yuan Xie, Malin Jarvius, Caroline Haglund, (unknown), Sara K. Olofsson, Nanna Lindberg, Tommie Olofsson, Göran Hesselager, Irina Alafuzoff, Mårten Fryknäs, Rolf Larsson, Sven Nelander, Lene Uhrbom	0
7	Identification of an inhibitor of the ubiquitin–proteasome system that induces accumulation of polyubiquitinated proteins in the absence of blocking of proteasome function 2014 ·MedChemComm ·Caroline Haglund, (unknown), Mårten Fryknäs, Pádraig D’Arcy, Rolf Larsson, Stig Linder, Linda Rickardson	4
8	Piperlongumine induces inhibition of the ubiquitin–proteasome system in cancer cells 2013 ·Biochemical and Biophysical Research Communications ·Malin Jarvius, Mårten Fryknäs, Pádraig D’Arcy, C. N. Sun, Linda Rickardson, Joachim Gullbo, Caroline Haglund, Peter Nygren, Stig Linder, Rolf Larsson	50
9	Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system 2012 ·Investigational New Drugs ·Jenny Felth, (unknown), Pádraig D’Arcy, Caroline Haglund, Joachim Gullbo, Rolf Larsson, Stig Linder, Lars Bohlin, Mårten Fryknäs, Linda Rickardson	20
10	In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues 2011 ·Cancer Chemotherapy and Pharmacology ·Caroline Haglund, Anna Åleskog, Peter Nygren, Joachim Gullbo, Martin Höglund, Malin Wickström, Rolf Larsson, Elin Lindhagen	27
11	Identification of Agents that Induce Apoptosis of Multicellular Tumour Spheroids: Enrichment for Mitotic Inhibitors with Hydrophobic Properties 2011 ·Chemical Biology & Drug Design ·Walid Fayad, Linda Rickardson, Caroline Haglund, Maria Hägg Olofsson, Pádraig D’Arcy, Rolf Larsson, Stig Linder, Mårten Fryknäs	37
12	The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing 2010 ·Toxicology Letters ·Caroline Haglund, Anna Åleskog, Lena Håkansson, Martin Höglund, Stefan Jacobsson, Rolf Larsson, Elin Lindhagen	16
13	Primary lymphocytes as predictors for species differences in cytotoxic drug sensitivity 2007 ·Toxicology in Vitro ·(unknown), Caroline Haglund, (unknown), Rolf Larsson, Elin Lindhagen	13
14	The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro 2007 ·Investigational New Drugs ·Malin Wickström, Caroline Haglund, Henrik Lindman, Peter Nygren, Rolf Larsson, Joachim Gullbo	32
15	Screening of an annotated compound library for drug activity in a resistant myeloma cell line 2006 ·Cancer Chemotherapy and Pharmacology ·Linda Rickardson, Mårten Fryknäs, Caroline Haglund, Henrik Lövborg, Peter Nygren, Mats G. Gustafsson, Anders Isaksson, Rolf Larsson	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact